7th International Symposium on NeuroVirology

描述（由申请人提供）：本申请为第七届国际神经病毒学研讨会寻求支持，该会议将于2006年5月30日至6月3日在宾夕法尼亚州费城举行，为期3.5天，部分由国际神经病毒学学会（ISNV）赞助。这次专题讨论会将是1997年开始的一系列讨论会中的第七次。具体来说，申请要求资金用于支付以下费用：(1)全体会议发言人，(2)研究生，博士后和临床研究员的差旅费，(3)准备现场注册包材料，(4)海报会议费用，(5)租用视听设备，(6)租用研讨会和海报会议的房间，(7)与注册，计划准备，抽象处理相关的行政工作。(8)所有会议活动的网络管理。第七届国际神经病毒学研讨会的具体目的是提供一个论坛，传播有关以下方面的新信息：(1)炎症性疾病的机制，(2)神经艾滋病，(3)多发性硬化症，(4)HAM/TSP,(5)流感和病毒性脑炎，(6)非病毒性中枢神经系统感染，(7)衰老和中枢神经系统病毒感染，(8)共病病原体，(9)神经精神疾病和滥用药物，（10）宿主和病毒遗传学，（11）病毒潜伏期和再激活，（12）神经发生、造血和细胞治疗。第七届研讨会还将(1)加强有关艾滋病毒和其他一些病毒和非病毒病原体引起的神经系统疾病的预防和治疗的基础/临床科学概念的交流，(2)促进年轻研究人员对一个重要和不断发展的多学科研究领域的吸引力（研究人员培训会议和网络午餐），(3)促进国际范围内的合作，包括培育世界欠发达地区的研究；(4)强调基本科学概念和教条的发展（科学范式建设讲座）；(5)强调杰出女性在生物医学科学发展中的主要贡献（杰出女性科学讲座）。总的来说，第七届国际神经病毒学研讨会将寻求向神经病毒学和相关学科领域的研究人员提供最新的前沿信息，以便继续确定知识方面的重要空白。有了这些信息，与会者将努力制定新的问题和实验方向，以加强新策略的发展，以预防、诊断和治疗与朊病毒、HIV和其他病毒和非病毒病原体相关的神经系统疾病。预计将有大约350人参加第七届国际神经病毒学研讨会，其中有250多篇摘要和50多篇口头报告。

DESCRIPTION (provided by applicant): This application seeks support for the 7th International Symposium on NeuroVirology that will be held as a 3.5 day meeting scheduled for May 30 - June 3, 2006 in Philadelphia, Pennsylvania and sponsored, in part, by the International Society for NeuroVirology (ISNV). This symposium will be the seventh in a series that was initiated in 1997. Specifically, the application requests funding to cover the costs of (1) plenary session speakers, (2) travel grants for graduate students, postdoctoral fellows, and clinical fellows, (3) preparation of on-site registration packet materials, (4) poster session costs, (5) rental of audiovisual equipment, (6) rental of rooms for workshop and poster sessions, (7) administrative effort associated with registration, program preparation, abstract processing, and general meeting preparation activities, and (8) web-based management of all meeting activities. The specific aims of the 7th International Symposium on NeuroVirology are to provide a forum for the dissemination of new information related to (1) mechanisms of inflammatory disease, (2) NeuroAIDS, (3) Multiple Sclerosis, (4) HAM/TSP, (5) influenza and viral encephalitis, (6) non-viral CNS infections, (7) aging and CNS viral infection, (8) comorbidity pathogens, (9) neuropsychiatric disease and drugs of abuse, (10) host and viral genetics, (11) viral latency and reactivation, and (12) neurogenesis, hematopoiesis, and cellular therapy. The 7th Symposium will also (1) enhance cross-fertilization of basic/clinical science concepts concerning prevention and treatment of neurologic disease caused by HIV and a number of other viral and non-viral pathogens, (2) facilitate the attraction of young investigators to an important and growing multi-disciplinary field of investigation (Investigators-in-Training sessions and networking lunches), (3) stimulate collaborations with an international scope including the nurturing of research in underdeveloped regions of the world, (4) emphasize the development of basic scientific concepts and dogma (Scientific Paradigm Building Lecture), and (5) emphasize the major contributions of outstanding women in the development of biomedical science (Women's Excellence in Science Lecture). Overall, the 7th International Symposium on NeuroVirology will seek to update investigators working in the field of neurovirology and related disciplines with leading edge information so that important gaps in knowledge can continue to be identified. Armed with this information, attendees will work toward formulating new questions and experimental directions to enhance the development of new strategies to prevent, diagnose, and treat neurologic disease associated with prions, HIV, and other viral and non-viral pathogens. It is anticipated that approximately 350 individuals will attend the 7th International Symposium on NeuroVirology with more than 250 abstracts and greater than 50 oral presentations.